Charles River Laboratories International Inc.
Income Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Revenue | $1.17B | $1.30B |
| Cost of Revenue | $255.7M | $252.9M |
| Gross Profit | $916.0M | $1.04B |
| Gross Margin | 78.2% | 80.5% |
| Operating Expenses | ||
| Research & Development | — | — |
| SG&A Expense | $227.7M | $223.9M |
| Operating Income | $169.6M | $-451.8M |
| Operating Margin | 14.5% | -34.9% |
| Interest Expense | $21.7M | $22.3M |
| Pretax Income | $151.6M | $-471.4M |
| Income Tax Expense | $40.4M | $57.0M |
| Net Income | $114.4M | $-524.5M |
| Net Margin | 9.8% | -40.5% |
| EPS (Basic) | $1.75 | $-7.80 |
| EPS (Diluted) | $1.74 | $-7.80 |
| Shares Outstanding (Basic) | 65.4M | — |
| Shares Outstanding (Diluted) | 65.6M | — |
| Dividends Per Share | — | — |